SON advances requirements for African conventional medication development

The Requirements Organisation of Nigeria has reaffirmed its dedication to selling African conventional medication by creating internationally aggressive requirements.

This was emphasised throughout the 18th Nationwide Technical Mirror Committee assembly on African Conventional Drugs held lately at Lagos State University in Lagos.

In his opening handle, SON Director-Normal, Dr. Ifeanyi Okeke, represented by the Director of Requirements Growth, Engr. Yahaya Bukar, lauded the committee’s achievements since its inception in 2015.

He counseled the chairperson, Prof. Maurice Iwu, for his management, which has positioned Nigeria as a pioneer in formulating and adopting African regional requirements for conventional medication.

Okeke highlighted that Nigeria has developed ten ARS for conventional medication, with plans to undertake a further 14 requirements, bringing the full to 24.

He famous these requirements improve high quality assurance, security, and compatibility, thus bolstering shopper and enterprise belief globally.

The SON chief emphasised the important position of those requirements in facilitating world market entry for Nigerian merchandise, lowering commerce boundaries, and guaranteeing compliance with worldwide laws. He reassured stakeholders of SON’s dedication to selling and implementing these requirements for native and world acceptance.

Vice Chancellor of LASU, represented by Deputy Vice-Chancellor (Admin) Prof. Adenike Omotunde, described the assembly as pivotal for fostering collaboration and innovation in conventional medication. She praised SON’s efforts in setting benchmarks to reinforce the protection and efficacy of conventional cures, which she believes are integral to Nigeria’s healthcare future.

Prof. Maurice Iwu, chairperson of the NTMC, urged individuals to speed up their efforts in creating requirements to allow Nigeria to compete with world leaders like India and China within the conventional medication sector.

He emphasised the financial potential of conventional African medication and its significance for future generations.

The assembly bolstered SON’s dedication to positioning Nigerian conventional medication on the worldwide stage by guaranteeing high quality, security, and compatibility, creating alternatives for financial improvement and healthcare innovation.